MedCity News February 3, 2021
Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?
Following in the footsteps of its digital health competitors, Livongo and Omada Health, Onduo recently added programs for hypertension and mental wellness to its diabetes platform.
Given that these conditions frequently overlap, it’s no surprise that Onduo, a subsidiary of Alphabet’s Verily, expanded in this direction. But how will it differentiate itself from the competition?
Onduo CEO Dr. Vindell Washington said Onduo’s more individualized approach, which considers health factors outside of the clinic, sets it apart from others.
“Most solutions take what I would...
Today's Sponsors
Today's Sponsor